These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 2407992

  • 1. [Bone tissue and cancer].
    Rossi JF.
    Pathol Biol (Paris); 1990 Jan; 38(1):69-79. PubMed ID: 2407992
    [Abstract] [Full Text] [Related]

  • 2. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K.
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [Abstract] [Full Text] [Related]

  • 3. Bone remodeling, normal and abnormal: a biological basis for the understanding of cancer-related bone disease and its treatment.
    Parfitt AM.
    Can J Oncol; 1995 Dec; 5 Suppl 1():1-10. PubMed ID: 8853518
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M.
    APMIS Suppl; 1997 Dec; 71():1-30. PubMed ID: 9357492
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Development, physiology, and cell activity of bone].
    de Baat P, Heijboer MP, de Baat C.
    Ned Tijdschr Tandheelkd; 2005 Jul; 112(7):258-63. PubMed ID: 16047964
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms of bone lesions in multiple myeloma.
    Bataille R, Chappard D, Klein B.
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):285-95. PubMed ID: 1582975
    [Abstract] [Full Text] [Related]

  • 9. The mechanisms of bone lesions in human plasmacytomas.
    Bataille R.
    Stem Cells; 1995 Aug; 13 Suppl 2():40-7. PubMed ID: 8520510
    [Abstract] [Full Text] [Related]

  • 10. Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma.
    Bataille R, Chappard D, Marcelli C, Dessauw P, Baldet P, Sany J, Alexandre C.
    J Clin Invest; 1991 Jul; 88(1):62-6. PubMed ID: 2056131
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Morphology and biochemistry of bone remodeling: possible control by vitamin D, parathyroid hormone, and other substances.
    Huffer WE.
    Lab Invest; 1988 Oct; 59(4):418-42. PubMed ID: 3050272
    [Abstract] [Full Text] [Related]

  • 14. [How is bone formed and resorbed?-- molecular mechanisms of bone formation and resorption].
    Suda T.
    Rinsho Byori; 2002 Mar; 50(3):267-72. PubMed ID: 11985054
    [Abstract] [Full Text] [Related]

  • 15. Bone remodeling.
    Hadjidakis DJ, Androulakis II.
    Ann N Y Acad Sci; 2006 Dec; 1092():385-96. PubMed ID: 17308163
    [Abstract] [Full Text] [Related]

  • 16. Advances in the biology of bone metastasis: how the skeleton affects tumor behavior.
    Sterling JA, Edwards JR, Martin TJ, Mundy GR.
    Bone; 2011 Jan; 48(1):6-15. PubMed ID: 20643235
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The dual role of IL-6-type cytokines on bone remodeling and bone tumors.
    Blanchard F, Duplomb L, Baud'huin M, Brounais B.
    Cytokine Growth Factor Rev; 2009 Feb; 20(1):19-28. PubMed ID: 19038573
    [Abstract] [Full Text] [Related]

  • 19. Osteoclasts constitutively express regulators of bone resorption: an immunohistochemical and in situ hybridization study.
    O'Keefe RJ, Teot LA, Singh D, Puzas JE, Rosier RN, Hicks DG.
    Lab Invest; 1997 Apr; 76(4):457-65. PubMed ID: 9111508
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.